The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, however its legacy within the broader sector now raises questions about future yields . Generic versions are diminishing market share, leading to worries that investing in companies heavily reliant to Viagra's previous influence could be a problematic s